Need help? Call Or Text us, and a team member will be happy to assist you. +1 (855) 322-2214
Need help? Call Or Text us, and a team member will be happy to assist you. +1 (855) 322-2214
Thymosin Beta-4 Fragments: Functions, Differences, and When to Use Each
Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law.
Overview
Thymosin Beta-4 (Tβ4) is a 43–amino acid peptide best known for orchestrating tissue repair: it mobilizes cells, tempers inflammation, protects against injury, and supports angiogenesis. Beyond the full-length peptide, several bioactive fragments have been identified. Each fragment retains a distinct slice of Tβ4’s biology—ranging from anti-apoptotic protection to anti-fibrotic signaling and hair-follicle activation—creating opportunities for more targeted applications.
What Is Thymosin Beta-4?
Tβ4 is widely expressed and upregulated following tissue injury. A major actin-sequestering protein, it promotes cell migration, limits scar formation, and exhibits anti-inflammatory activity. Preclinical and clinical research has explored Tβ4 across cardiovascular, neurologic, ophthalmic, dermatologic, and musculoskeletal settings, where it helps coordinate repair and remodeling.
How Tβ4 Works
Tβ4 is present in skeletal and smooth muscle and rises after trauma. Core mechanisms include:
- Actin binding & cell motility: speeds re-epithelialization and structural repair.
- Inflammation control: down-modulates pro-inflammatory cytokines, reducing edema and fibrosis.
- Tissue remodeling: supports angiogenesis, extracellular-matrix organization, and adhesion prevention.
- Cytoprotection: limits apoptosis and oxidative damage, preserving function.
While the parent peptide drives broad repair, specific fragments capture focused effects that may be preferable for defined goals.
The Major Thymosin Beta-4 Fragments
1) Full-Length Tβ4 (43 aa): Broad-Spectrum Repair
Sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser
Profile: Comprehensive wound-healing program—actin sequestration and migration, angiogenesis, inflammation control, anti-apoptosis, and neuroprotection. Also reported to support hair-follicle cycling in topical use. Ideal when systemic or multi-tissue effects are desired.
2) Tβ4 (1-15): Anti-Apoptotic, Pro-Survival Shield
Focus: Cell-survival signaling and resistance to oxidative/ischemic stress (e.g., neurons, corneal and renal cells).
Mechanisms: Modulates caspases and Bcl-2/Bax balance; attenuates senescence signals.
Use case: Situations where cytoprotection is the priority (neuroprotection, kidney support, ischemic injury), more than angiogenesis or broad matrix remodeling.
3) Tβ4 (1-4): Anti-Inflammatory & Anti-Fibrotic Modulator
Focus: Potent dampening of TNF-α, IL-1β, IL-6 and inhibition of NF-κB–driven pathways; limits excessive collagen deposition.
Use case: Inflammation- and fibrosis-dominant conditions (autoimmune activity, hepatic/pulmonary/cardiac fibrosis), where immune calibration and scar control are central.
4) Tβ4 (17-23) “LKKTETQ”: Actin-Binding for Wound Repair & Hair Growth
Focus: Direct actin binding to enhance cell migration; pro-angiogenic signaling; early wound-closure cues (including mast-cell exocytosis).
Distinctive trait: Hair-follicle activation and anagen entry in topical models.
Use case: Dermatology and post-procedure repair, scar-minimizing wound care, and hair-regrowth strategies.
5) Tβ4 (40-43): C-Terminal Motif Under Investigation
Focus: Emerging data suggest roles in actin dynamics, cell adhesion, and ECM interactions; independent bioactivity remains to be fully defined.
Use case: Exploratory—potential relevance to tissue stability and matrix remodeling pending further study.
Side-by-Side: How the Fragments Differ
| Fragment | Primary Actions | Key Benefits | Notable Uses |
| Full-Length Tβ4 (43 aa) | Broad repair, angiogenesis, anti-inflammatory, anti-apoptotic | Wound healing, tissue regeneration, neuroprotection, hair support | Systemic or multi-tissue needs |
| Tβ4 (1-15) | Anti-apoptotic, cytoprotection | Cell survival, neuroprotection, slower senescence signals | Kidney/neuronal ischemia, neurodegeneration contexts |
| Tβ4 (1-4) | Anti-inflammatory, anti-fibrotic | Cytokine reduction, NF-κB modulation, scar control | Autoimmune activity, hepatic/pulmonary/cardiac fibrosis |
| Tβ4 (17-23) | Actin binding, migration, angiogenesis | Faster wound closure, vascular support, hair-follicle activation | Dermatology, post-surgical repair, hair regrowth |
| Tβ4 (40-43) | Under study | Possible actin/ECM effects | To be determined |
Selecting the Right Fragment
- Cellular protection & healthy aging: Tβ4 (1-15)
- Inflammation/fibrosis control: Tβ4 (1-4)
- Wound healing & hair growth: Tβ4 (17-23)
- Broad, system-level remodeling: Full-length Tβ4
As peptide science advances, these fragments enable precision applications of Tβ4 biology—deploying only the functions needed for the job at hand while minimizing unnecessary signals.
Product available for research use only:
References:
Wang M, Feng LR, Li ZL, et al. Thymosin β4 reverses phenotypic polarization of glial cells and cognitive impairment via negative regulation of NF-κB signaling axis in APP/PS1 mice. J Neuroinflammation. 2021;18(1):146. Published 2021 Jun 28. doi:10.1186/s12974-021-02166-3
Pardon MC. Anti-inflammatory potential of thymosin β4 in the central nervous system: implications for progressive neurodegenerative diseases. Expert Opin Biol Ther. 2018;18(sup1):165-169. doi:10.1080/14712598.2018.1486817
Xiong Y, Mahmood A, Meng Y, Zhang Y, Zhang ZG, Morris DC, Chopp M. Treatment of traumatic brain injury with thymosin β₄ in rats. J Neurosurg. 2011 Jan;114(1):102-15. doi: 10.3171/2010.4.JNS10118. Epub 2010 May 21. PMID: 20486893; PMCID: PMC2962722.
Morris DC, Chopp M, Zhang L, Zhang ZG. Thymosin beta4: a candidate for treatment of stroke? Ann N Y Acad Sci. 2010 Apr;1194:112-7. doi: 10.1111/j.1749-6632.2010.05469.x. PMID: 20536457; PMCID: PMC3146053.
Zhang G, Murthy KD, Binti Pare R, Qian Y. Protective effect of Tβ4 on central nervous system tissues and its developmental prospects. European Journal of Inflammation. 2020;18. doi:10.1177/2058739220934559
Xing Y, Ye Y, Zuo H, Li Y. Progress on the Function and Application of Thymosin β4. Front Endocrinol (Lausanne). 2021 Dec 21;12:767785. doi: 10.3389/fendo.2021.767785. PMID: 34992578; PMCID: PMC8724243.


